Le Lézard
Classified in: Science and technology
Subject: PDT

500,000 New Biometric Driver's Licenses per Month


MANILA, Philippines, Dec. 12, 2017 /CNW/ - Exactly 3 months ago, Philippines' Land Transport Office LTO started issuing its first new biometric driver's licenses in Metro Manila. Now that the nationwide launch of the system has been successfully completed, LTO issues 500,000 licenses per month. DERMALOG, the German innovation leader in biometrics, supplied the cards and system.

(Photo: http://mma.prnewswire.com/media/611402/DERMALOG.jpg)

Assistant Secretary Edgar Galvante of LTO said: "We are happy that the new system is replacing the backlog of the old paper based intermediate driver´s licenses very fast and effective. LTO is confident that the full backlog will be cleared until April 2018."

DERMALOG's CEO Günther Mull mentioned: "We are proud that the ambitious time frame of LTO could be fulfilled. The system went live after 4 months and - with the help of LTO - the national rollout was completed within another 3 months at all 257 locations."

With 32 security features and its fingerprint biometrics, the license is currently the most secure identification card in the Philippines. Fingerprints of each applicant are automatically checked against the central database of LTO. DERMALOG´s Automated Fingerprint Identification System (AFIS) prevents from double identities. More than 20 attempts to obtain a second driver´s license under a different name were prevented by the DERMALOG AFIS in the initial phase.

Normally the card issuing time from registration to printing is less than 10 minutes. However, "printing" is not exactly the right word. The data are now engraved by laser engraver machines into the card material, which guarantees none erasure and prevents from alteration. Furthermore, the new cards can last up to 10 years.

SOURCE DERMALOG Identification Systems GmbH


These press releases may also interest you

at 07:05
Aldeyra Therapeutics, Inc. (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the clinical development plan intended to enable...

at 07:05
Mythic Therapeutics, a clinical-stage biotechnology company committed to the development of next-generation antibody-drug conjugate (ADC) therapies for the treatment of a wide range of cancers, announced that George Eliades, Ph.D., has joined the...

at 07:05
WorkForce Software, the #1 rated workforce management solution for large employers, is pleased to announce the appointment of Marc Havercroft as Senior Vice President of International Sales. In this role, Havercroft will lead the company's...

at 07:05
Seres Therapeutics, Inc. ("Seres" or the "Company"), a leading microbiome therapeutics company, today announced that on March 25, 2024, the Compensation and Talent Committee of Seres' board of directors granted inducement equity grants covering an...

at 07:05
Fox Lake Grade School District 114 today announced a partnership with Varsity Tutors for Schools, a Nerdy company and the leading platform for live online tutoring, to provide its Stanton Middle School students with access to the Varsity Tutors for...

at 07:05
Gilead Sciences, Inc. and Xilio Therapeutics, Inc. today announced an exclusive license agreement to develop and commercialize Xilio's Phase 1 tumor-activated IL-12 program, XTX301. Xilio Therapeutics is a clinical-stage biotechnology company...



News published on and distributed by: